These findings are consistent with those from a small prospective study (n = 699 and 24 cancer cases) in coronary disease patients, linking NT-proBNP with overall cancer risk [42], and support findings from a retrospective study showing that BNP levels are elevated in cancer patients [54]. Here, NPPB is linked to cancer.